Home › Compound guides › Cagrilintide

Compound guide

What Is Cagrilintide?

The long-acting amylin analog behind the “CagriSema” research pairing — what it is, how it works, and how it’s handled, in plain English.

Cagrilintide is one of the more interesting peptides in current metabolic research, because it works on a pathway most of the well-known compounds don’t touch. While semaglutide and tirzepatide act on the incretin (GLP-1) system, cagrilintide targets a separate hormone entirely — which is exactly why researchers study the two together.

Research use only. This article is an educational overview of an investigational compound. It is not medical advice, makes no treatment or dosing recommendations, and does not describe human use.

What is cagrilintide?

Cagrilintide is a synthetic, long-acting analog of amylin — a hormone the pancreas co-releases with insulin. In its natural form amylin is short-lived; cagrilintide is engineered to be stable enough for once-weekly use in trials. It acts as an amylin-receptor agonist and is supplied to researchers as a lyophilized powder for laboratory use only.

How does it work?

Amylin is part of the body’s satiety and glucose-signalling system, working alongside insulin. Because that pathway is separate from the GLP-1 pathway, cagrilintide is studied as a way to engage metabolic signalling from a different angle than the GLP-1 agonists.

GLP-1 agonists work on the incretin system; cagrilintide works on the amylin system — two different levers, which is why they’re studied side by side.

Cagrilintide and semaglutide: the “CagriSema” pairing

The reason cagrilintide gets so much attention is the research pairing with semaglutide, informally called CagriSema. The logic is straightforward: combine two compounds that act on different metabolic pathways rather than doubling up on one.

CompoundPathwayClass
CagrilintideAmylinAmylin analog
SemaglutideGLP-1GLP-1 agonist
The pairingAmylin + GLP-1Dual-pathway research combo

Each is its own compound with its own research profile — the interest is in how two distinct pathways behave when studied together.

How is cagrilintide handled in the lab?

Like most research peptides, cagrilintide arrives as a lyophilized (freeze-dried) powder. Before it can be used in solution it has to be reconstituted:

Why purity matters

With an investigational peptide, knowing exactly what is in the vial is everything. A reputable source provides a Certificate of Analysis (COA) showing third-party HPLC purity and mass-spec identity for that specific batch. If you are not sure how to read one, see what is a COA.

Where to buy

Sourcing research-grade cagrilintide

We recommend Vital Chems for tested compounds and bacteriostatic water.

  • Third-party HPLC tested — COA on every order
  • Same-day shipping before 1:30 PM PT
  • US-based, fast and responsive support
Visit Vital Chems →

Frequently asked questions

What is cagrilintide?
A long-acting synthetic analog of the hormone amylin. It acts as an amylin-receptor agonist, is studied in metabolic research, and is supplied as a lyophilized powder for research use only.
How is cagrilintide different from semaglutide?
They act on different pathways: semaglutide is a GLP-1 agonist, while cagrilintide is an amylin analog. That difference is why they are studied together.
What is CagriSema?
An informal name for the research pairing of cagrilintide with semaglutide — two compounds acting on separate metabolic pathways (amylin and GLP-1).
Is cagrilintide approved?
No. It is investigational and studied for research use only. Nothing here describes or recommends human use.
P

Peptide Starter Guide

Plain-English guides to handling research peptides correctly — reconstitution, dosing math, purity, and storage. Written for first-timers.